Specific T-cell subsets can predict the efficacy of anti-TNF treatment in inflammatory bowel diseases

• Autorzy: Dulic S. , Toldi G. , Sava F. , Kovacs L. , Molnar T. , Milassin A. , Farkas K. , Rutka M. , Balog A.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

tumour necrosis factor; T lymphocyte; inflammatory bowel disease; Crohn's disease; ulcerative colitis; Th17 cell; Th2 cell; patient

• Wydawca: -
• Czasopismo: Archivum Immunologiae et Therapiae Experimentalis
• Rocznik: 2020
• Tom: 68
• Numer: 2
• Opis fizyczny: Article 12 [10p.], fig.,ref.

Twórcy

autor

Dulic S.

• Department of Rheumatology and Immunology, Faculty of Medicine, Albert Szent-Gyorgyi Health Center, University of Szeged, Kalvaria sgt. 57, Szeged, 6725, Hungary

autor

Toldi G.

• First Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary

autor

Sava F.

• First Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary

autor

Kovacs L.

• Department of Rheumatology and Immunology, Faculty of Medicine, Albert Szent-Gyorgyi Health Center, University of Szeged, Kalvaria sgt. 57, Szeged, 6725, Hungary

autor

Molnar T.

• First Department of Medicine, Faculty of Medicine, Albert Szent-Gyorgyi Health Center, University of Szeged, Szeged, Hungary

autor

Milassin A.

• First Department of Medicine, Faculty of Medicine, Albert Szent-Gyorgyi Health Center, University of Szeged, Szeged, Hungary

autor

Farkas K.

• First Department of Medicine, Faculty of Medicine, Albert Szent-Gyorgyi Health Center, University of Szeged, Szeged, Hungary

autor

Rutka M.

• First Department of Medicine, Faculty of Medicine, Albert Szent-Gyorgyi Health Center, University of Szeged, Szeged, Hungary

autor

Balog A.

• Department of Rheumatology and Immunology, Faculty of Medicine, Albert Szent-Györgyi Health Center, University of Szeged, Kalvaria sgt. 57, Szeged, 6725, Hungary

Identyfikatory

DOI

10.1007/s00005-020-00575-5